| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/13/2008 | US7371755 Antiviral agents |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/13/2008 | US7371746 1,2,4-Thiadiazole compounds and pests controlling composition containing the same |
| 05/13/2008 | US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/13/2008 | CA2279939C Treatment and prevention of adhesions |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053812A1 Cyanopyridine derivative and medicinal use thereof |
| 05/08/2008 | WO2008053764A1 Anti-prion active compound, anti-prion active agent, and method for inhibition of the production of abnormal prion protein |
| 05/08/2008 | WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative |
| 05/08/2008 | WO2008053352A2 Phenylpropionamide compounds and the use thereof |
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 05/08/2008 | WO2008053158A1 Inhibitors of p38 mitogen-activated protein kinase |
| 05/08/2008 | WO2008053157A1 Aminoheteroaryl compounds as for the treatment of diseases mediated by c-met kinase activity |
| 05/08/2008 | WO2008052934A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 05/08/2008 | WO2008052907A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors |
| 05/08/2008 | WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 05/08/2008 | WO2008052808A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/08/2008 | WO2008052769A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/08/2008 | WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 05/08/2008 | WO2008028935A3 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 05/08/2008 | WO2008011109A3 Substituted pyridone compounds and methods of use |
| 05/08/2008 | US20080108822 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's |
| 05/08/2008 | US20080108821 Method for preparing 3-halo-4,5-dihydro-1H-pyrazoles |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108819 Novel indole derivatives and their use as medicament |
| 05/08/2008 | US20080108817 Colorant compositions |
| 05/08/2008 | US20080108814 For treatment of various forms of neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease |
| 05/08/2008 | US20080108810 Prepared by reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting product with an alkali metal salt of a malonate diester to replace 4-fluoro group with malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation; use in treatment of HIV |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108671 Non-systemic control of parasites |
| 05/08/2008 | US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 05/08/2008 | US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc |
| 05/08/2008 | US20080108664 Antiangiogenic; N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide (AMG 706) |
| 05/08/2008 | US20080108661 N-{3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-2-hydroxypropyl}-2,3-dihydro-2-oxo-4-(trifluoromethyl)-5-thiazolecarboxamide; chemokine receptor CCR3 modulator and histamin receptor H1 antagonist; antiinflammatory agent, antiallergen; asthma, rhinitis, COPD, osteoarthritis or osteoarthrosis |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108659 Poly(adp-ribose)polymerase inhibitors |
| 05/08/2008 | US20080108654 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108638 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 05/08/2008 | US20080108634 Novel phenylalanine derivatives |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108627 9-[(3-hydroxy-5-methoxyphenyl)amino]-1,2-dihydrothieno[3,2-f]quinoline-8-carbonitrile 3,3-dioxide; protein tyrosine kinases inhibitor, especially erythropoetin-producing hepatoma amplified sequence (Eph) receptors antagonist; antitumor, angiogenesis inhibitor, neurodegenerative diseases |
| 05/08/2008 | US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 05/08/2008 | US20080108625 Substituted Triazole Derivatives as Oxytocin Antagonists |
| 05/08/2008 | US20080108624 Methylene Dipiperidine Derivatives |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108609 Benzoxazole Carboxamides For Treating CINV and IBS-D |
| 05/08/2008 | US20080108608 Pyrimidines With Tie2 (Tek) Activity |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same |
| 05/08/2008 | CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 05/08/2008 | CA2668454A1 Substituted 2-imidazoles |
| 05/08/2008 | CA2668006A1 Substituted pyridin-3-yl amides as 1.beta.hsd1 inhibitors |
| 05/08/2008 | CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 05/08/2008 | CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | CA2666750A1 Phenylpropionamide compounds and the use thereof |
| 05/07/2008 | EP1918284A1 Hydrazinopyrimidines as cysteine protease inhibitors |
| 05/07/2008 | EP1918281A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918277A2 Azulene compounds |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917979A1 Therapeutic agent for atrial fibrillation |
| 05/07/2008 | EP1917963A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/07/2008 | EP1917323A1 Novel materials for organic electroluminescent devices |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917257A1 Substituted triazole derivatives as oxytocin antagonists |
| 05/07/2008 | EP1917256A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 05/07/2008 | EP1917255A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 05/07/2008 | EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors |
| 05/07/2008 | EP1917246A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 05/07/2008 | EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917240A1 Immunosuppressant compounds and compositions |
| 05/07/2008 | EP1761519B1 Indole derivatives as histamine receptor antagonists |
| 05/07/2008 | EP1603880B1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 05/07/2008 | EP1603874B1 G-lactam derivatives as prostaglandin agonists |
| 05/07/2008 | EP1601670B1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/07/2008 | EP1575963B1 Anti-angiogenetic therapeutic agents |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | EP1390347B1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 05/07/2008 | CN101175750A Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 05/07/2008 | CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 05/07/2008 | CN101175747A Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 05/07/2008 | CN101175729A 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
| 05/07/2008 | CN101175726A Process for the preparation of opioid modulators |
| 05/07/2008 | CN101175725A Process for the preparation of opioid modulators |